CIRculating CANcer MAster-Protocol

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

6000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-12-05

Study Completion Date

2047-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Analysis of Circulating Tumor Markers in Blood - ALCINA 5

NCT07060950

Cancer Lung Cancer, Non-Small Cell

NOT_YET_RECRUITING NA

Screening Study for Participants With Malignant Tumors

NCT05419375

Solid Tumors

RECRUITING PHASE2

Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

NCT05530759

Hematopoietic and Lymphoid System Neoplasm Metastatic Malignant Solid Neoplasm

RECRUITING

Analysis of Circulating Tumor Markers in Blood

NCT04025541

Cancer Breast Cancer Sarcoma +3 more

RECRUITING NA

A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer

NCT05574738

Cancer

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adult With Solid Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult with solid cancer. No intervention.

Blood sampling for biomarker analysis (microRNA, circulating DNA…)

Intervention Type BIOLOGICAL

From one to four blood samplings: at diagnosis, after the first cycle of treatment, end of treatment, progressive disease (or end of study).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood sampling for biomarker analysis (microRNA, circulating DNA…)

From one to four blood samplings: at diagnosis, after the first cycle of treatment, end of treatment, progressive disease (or end of study).

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (\>18y)
* Owing a social security insurance
* Any solid cancer diagnosed by histopathology or cytology
* Patient with blood sampling required as per standard of care
* Informed consent signed

Exclusion Criteria

* Refusal to participate
* No blood sampling required as per standard of care
* Hemoglobin \< 7g/dl (\< 9g/dl if respiratory or cardiovascular disease history)
* Heterologous blood transfusion in the last 48 hours
* Weight under 20 kg

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No